[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-393905-105":59,"doc-detail-393905-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","towards-standardizing-a-framework-for-models-of-alzheimers-disease","Towards Standardizing a Framework for Models of Alzheimer's Disease","","This document outlines a framework for understanding and modeling Alzheimer's disease, emphasizing the necessity of grounding models in the human disease's canonical features. It explores the relationship between cognitive impairment and various etiologies, including cerebrovascular conditions, synucleinopathies, and frontotemporal degenerations. The content details core neuropathologic features, biomarkers such as amyloid PET and CSF tau, and the sequential progression of biological and clinical changes from the presymptomatic phase through symptomatic dementia. Additionally, it examines the interplay between genetic factors like APOE4 and the age of onset in both sporadic and inherited forms of Alzheimer's disease. The presentation serves as a scholarly overview for advancing research and clinical assessments in the field of dementia.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/towards-standardizing-a-framework-for-models-of-alzheimers-disease/393905/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/towards-standardizing-a-framework-for-models-of-alzheimers-disease/393905.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-26",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What are the primary biomarkers used to assess Alzheimer's disease?","Question",{"text":113,"@type":114},"Key biomarkers include amyloid PET imaging, low CSF amyloid levels, volumetric MRI findings, temporo-parietal hypometabolism, and elevated CSF tau levels.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the document describe the relationship between cognitive impairment and other etiologies?",{"text":118,"@type":114},"Cognitive impairment serves as a central clinical manifestation that can be associated with various underlying etiologies, including Alzheimer's disease, cerebrovascular disease, synucleinopathies, and frontotemporal degenerations.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the significance of the distinction between sporadic and inherited AD?",{"text":122,"@type":114},"The document highlights that sporadic AD and dominantly inherited forms (linked to APP/PS1/PS2 mutations) are influenced by genetic modifiers such as APOE4, which affect the age of disease onset and clinical progression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},393905,1790872085,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","Towards Standardizing a Framework for models of Alzheimer’s Disease  \nThis symposium was conceived independently, but with the subsequent input, of:  \n– Zaven Khachaturian  \n– Marsel Mesulam  \n– Ara Khachaturian  \n– Richard Mohs  \n…who have developed a new Special Topics section for Alzheimer’s & Dementia to “assess the current state of knowledge related to the conceptual understanding of Alzheimer’s disease and dementia .”  \nCanonical AD: The Human Disease Where all models must start…  \nor end up  \nDavid Knopman MD Mayo Clinic Rochester MN  \nCore neuropathologic features of AD  \nArnold 1992  \nVariations in AD: Hippocampal sparing versus  \nLimbic Predominant  \nMurray, Lancet Neurology 2011  \nBiomarkers of AD  \nAmyloid PET   \nLow CSF Amyloid  \nVolumetric MR  \nTemporo-parietal hypometabolism  \nElevated CSF tau  \nSequential Biological & Clinical Changes in AD  \nseverity  \nBrain β-amyloidosis  \n••••  \nyears  \n0  \n-5  \n-40  \nPresymptomatic Earliest Dementia  \nsymptomatic  \nAge & Expression of Alzheimer Disease  \nProbability of PIB SUVR> 1.4  \n1. Jorm , Neurology1998  \n3. Braak, Neurobiol Aging1997  \n2. Jack, JAMA Neurol 2015  \nRelationship of dominantly inherited AD with genetic modifiers and “sporadic” AD  \nCumu lat ive Percent  \n100  \n75  \n50  \n25  \n0  \nAPP/PS1/PS2 APOE4  \nSporadic  \n40 50 60 70 80 90 100  \nAge  \nAmyloid Neurodegeneration Cognition","cbCaio1l3SnUOWDr","https://ap.wps.com/l/cbCaio1l3SnUOWDr","pdf",605924,11,"English","# Conceptual Understanding of Alzheimer's Disease\n## Core Neuropathologic Features\n## Biomarkers and Clinical Changes\n## Genetic Modifiers and Age of Onset\n## Etiological Relationships and Differential Diagnosis","[{\"question\":\"What are the primary biomarkers used to assess Alzheimer's disease?\",\"answer\":\"Key biomarkers include amyloid PET imaging, low CSF amyloid levels, volumetric MRI findings, temporo-parietal hypometabolism, and elevated CSF tau levels.\"},{\"question\":\"How does the document describe the relationship between cognitive impairment and other etiologies?\",\"answer\":\"Cognitive impairment serves as a central clinical manifestation that can be associated with various underlying etiologies, including Alzheimer's disease, cerebrovascular disease, synucleinopathies, and frontotemporal degenerations.\"},{\"question\":\"What is the significance of the distinction between sporadic and inherited AD?\",\"answer\":\"The document highlights that sporadic AD and dominantly inherited forms (linked to APP/PS1/PS2 mutations) are influenced by genetic modifiers such as APOE4, which affect the age of disease onset and clinical progression.\"}]","Towards Standardizing a Framework for Models of Alzheimer's Disease | PDF",1790395957,28]